Cargando…
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches
In approximately 15–20% of the patients diagnosed with breast cancer, it comprises the triple negative (TN) subtype, which until recently lacked targets for specific treatments and is known for its aggressive clinical behavior in patients with metastatic disease. TNBC is considered the most immunoge...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172210/ https://www.ncbi.nlm.nih.gov/pubmed/37079257 http://dx.doi.org/10.1007/s11864-023-01069-0 |